期刊文献+

非甾体消炎药的消化道损伤及防治 被引量:8

原文传递
导出
摘要 非甾体消炎药( NSAIDs)是目前应用最广泛的药物之一.NSAIDs是消化性溃疡主要发病因素之一,而且在上消化道出血中起重要作用[1].NSAIDs所致的严重胃肠并发症主要为消化道出血、穿孔及胃排空障碍.出血原因可以是NSAIDs所致的溃疡、黏膜糜烂等,也可以是NSAIDs使用前已存在的无症状溃疡[2].NSAIDs使严重胃肠并发症的危险性增加4~6倍.长期服用NSAIDs者有多达25%会发生溃疡病,若既往有消化性溃疡病史,发生率将高达50%,年累积发生率接近100%.2% ~4%会发生出血或穿孔.
作者 许乐
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第2期98-99,共2页 Chinese Journal of Internal Medicine
  • 相关文献

参考文献10

  • 1Dincer D,Duman A,Dikici H,et al. NSAID-related upper gastrointestinal bleeding: are risk factors considered during prophylaxis? Int J Clin Pract,2006,60:546-548.
  • 2孟凡冬,张澍田.老年人非甾体抗炎药相关性胃十二指肠损伤的防治[J].中华消化内镜杂志,2009,26(4):222-224. 被引量:10
  • 3Lanza FL,Chan FK,Quigley EM,et al.Guidelines for prevention of NSAID-related ulcer complications.Am J Gastroenterol,2009,104:728-738.
  • 4Lanas A. A review of the gastrointestinal safety data--a gastroenterologist's perspective.Rheumatology (Oxford),2010,49Suppl 2:ii3-10.
  • 5Lanas A. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.Am J Gastroenterol,2009,104:1633-1641.
  • 6Vergara M,Catalán M,Gisbert JP,et al.Meta-analysis:role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.Aliment Pharmacol Ther,2005,21:1411-1418.
  • 7Hooper L,Brown TJ,Elliott R,et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs:systematic review. BMJ,2004,329:948.
  • 8Lai KC,Lam SK,Chu KM,et al.Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.N Engl J Med,2002,346:2033-2038.
  • 9Fornai M,Colucci R,Antonioli L,et al.Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment:characterization of molecular mechanisms. Pharmacol Res,2011,63:59-67.
  • 10Rostom A,Muir K,Dubé C,et al. Gastrointestinal safety of cyclooxygenase-2 inhibitors:a Cochrane collaboration systematic review.Clin Gastroenterol Hepatol,2007,5:818-828.

二级参考文献9

  • 1Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology, 1999,117:17-25.
  • 2Moore A, Phillips C, Hunsche E, et al. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK. Pharmacoeconomics, 2004,22:643-660.
  • 3Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastreenterelogy. Am J Gastroenterol, 1998,93:2037-2046.
  • 4Hooper L, Brown TJ, Elliott R, et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ, 2004,329:948.
  • 5McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definition and epidemiology. Am J Med, 1998,105 ( Suppl 5 ) : S3-9.
  • 6Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med, 1999, 340 : 1888-1899.
  • 7Lanas A, Hirschowitz BI. Toxicity of NSAIDs in the stomach and duodenum. Eur J Gastroenterol Hepatol, 1999,11:375-381.
  • 8Champion GD, Feng PH, Azuma T, et al. NSAID-induced gastrointestinal damage. Epidemiology, risk and prevention, with an evaluation of the role of misoorostol. An Asia-Pacific perspective and consensus. Drugs, 1997,53:6-19.
  • 9Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am, 2000,29:97-124.

共引文献9

同被引文献48

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部